Journal of Pharmacogenomics & Pharmacoproteomics

Translational approaches and challenges for personalized cancer medicine

4^th International conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics

September 22-23, 2016 Phoenix, USA

Deepika Bhaskar

University of Delhi, India

Posters & Accepted Abstracts: J Pharmacogenomics Pharmacoproteomics

Abstract:

Since the Human Genome Project, the emerging scientific era of �??omics�?� has revolutionized the study of cancer. Cancer is driven fundamentally by genetic changes in a multistep progression still being understood, even in the most studied cancer types. Cancer Genome Consortiums are coordinating efforts aimed at identifying all genomic alterations significantly associated with cancer, including genomic loss or amplification, mutations in coding regions, chromosomal rearrangements, aberrant methylation and expression profiles that are discussed. The discovery stage targets the decoding of cancer genomes and using the knowledge for Personalized Cancer Medicine. This study also highlights technologies that empowers cancer genomics, compares and examines the results of genome sequencing and the challenges met in the discovery of new genetic aberrations and discuss the translation of cancer genomics to the clinic.

Biography :

Email: biodeepika@gmail.com